Publications by authors named "Kenneth D James"

Claim this Profile
I
In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis.
Dina A Boikov, Jeffrey B Locke, Kenneth D James, Ken Bartizal, Jack D Sobel

J Antimicrob Chemother· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of the Novel Echinocandin CD101 in Multiple Animal Species.
Voon Ong, Kenneth D James, Steven Smith, B Radha Krishnan

Antimicrob Agents Chemother· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD101, a novel echinocandin with exceptional stability properties and enhanced aqueous solubility.
B Radha Krishnan, Kenneth D James, Karen Polowy, B J Bryant, Anu Vaidya

J Antibiot (Tokyo)· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-Activity Relationships of a Series of Echinocandins and the Discovery of CD101, a Highly Stable and Soluble Echinocandin with Distinctive Pharmacokinetic Properties.
Kenneth D James, Christopher P Laudeman, Navdeep B Malkar, Radha Krishnan, Karen Polowy

Antimicrob Agents Chemother· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Evaluation of the Stability, Safety, and Efficacy of CD101, a Novel Echinocandin.
Voon Ong, Grayson Hough, Michael Schlosser, Ken Bartizal, James M Balkovec, Kenneth D James

Antimicrob Agents Chemother· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic actions of a novel oral B-type natriuretic peptide conjugate in normal dogs and acute actions in angiotensin II-mediated hypertension.
Alessandro Cataliotti, Horng H Chen, John A Schirger, Fernando L Martin, Guido Boerrigter, Kenneth D James

Circulation· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral brain natriuretic peptide: a novel strategy for chronic protein therapy for cardiovascular disease.
Alessandro Cataliotti, Horng H Chen, Kenneth D James, John C Burnett

Trends Cardiovasc Med· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amphiphilic conjugates of human brain natriuretic peptide designed for oral delivery: in vitro activity screening.
Mark A Miller, Navdeep B Malkar, Diana Severynse-Stevens, Kevin G Yarbrough, Mark J Bednarcik, Kenneth D James

Bioconjug Chem· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Congestive heart failure: pharmacological agents and the potential of B-type natriuretic Peptide.
Kenneth D James, Alessandro Cataliotti, John A Schirger, Shannon Plonka, John C Burnett

Curr Med Chem· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral human brain natriuretic peptide activates cyclic guanosine 3',5'-monophosphate and decreases mean arterial pressure.
Alessandro Cataliotti, John A Schirger, Fernando L Martin, Horng H Chen, Paul M McKie, Kenneth D James

Circulation· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis